Literature DB >> 7017731

Released protease-nexin regulates cellular binding, internalization, and degradation of serine proteases.

D A Low, J B Baker, W C Koonce, D D Cunningham.   

Abstract

Protease-nexin (PN), a component released by normal human fibroblasts into culture medium, forms covalent linkages with thrombin (Th) and the urinary plasminogen activator urokinase, apparently with their catalytic site serines. The present studies explored the function of PN by examining the interaction of protease-PN complexes with human fibroblasts and the consequences of this interaction. Th-PN and urokinase-PN complexes bind to cells via the PN portion of the complexes. The binding is selectively inhibited by heparin. Because PN has a heparin-binding site, this indicates that protease-PN complexes might bind to a cellular heparin-like site. After binding, the complexes are internalized. By inhibiting endocytosis with phenylarsine oxide, which does not affect cellular binding of Th-PN complexes, we showed that complexes must be internalized before they are degraded. Kinetic analysis of internalization and degradation of Th-PN showed that complexes are internalized more rapidly than they dissociate from the cell surface; by 120 min of incubation at 37 degrees C most cell-bound Th-PN complexes are degraded to amino acids. The results are summarized in a model showing how PN mediates the cellular binding, internalization, and degradation of serine proteases through formation of protease-PN complexes. This series of events may be involved in the regulation of serine protease activity at the cell surface and in the extracellular environment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7017731      PMCID: PMC319341          DOI: 10.1073/pnas.78.4.2340

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Thrombin and epidermal growth factor become linked to cell surface receptors during mitogenic stimulation.

Authors:  J B Baker; R L Simmer; K C Glenn; D D Cunningham
Journal:  Nature       Date:  1979-04-19       Impact factor: 49.962

2.  Conditions which affect initiation of animal cell division by trypsin and thrombin.

Authors:  D H Carney; K C Glenn; D D Cunningham
Journal:  J Cell Physiol       Date:  1978-04       Impact factor: 6.384

3.  Human thrombins. Production, evaluation, and properties of alpha-thrombin.

Authors:  J W Fenton; M J Fasco; A B Stackrow
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

4.  Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells.

Authors:  J B Baker; D A Low; R L Simmer; D D Cunningham
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

5.  Collection of insulin, EGF and alpha2-macroglobulin in the same patches on the surface of cultured fibroblasts and common internalization.

Authors:  F R Maxfield; J Schlessinger; Y Shechter; I Pastan; M C Willingham
Journal:  Cell       Date:  1978-08       Impact factor: 41.582

6.  Salt extraction of soluble HL-A antigens.

Authors:  R A Reisfeld; M A Pellegrino; B D Kahan
Journal:  Science       Date:  1971-06-11       Impact factor: 47.728

7.  Cell surface action of thrombin is sufficient to initiate division of chick cells.

Authors:  D H Carney; D D Cunningham
Journal:  Cell       Date:  1978-08       Impact factor: 41.582

8.  Localization of serum-derived alpha 2 macroglobulin in cultured cells and decrease after Moloney sarcoma virus transformation.

Authors:  I Pastan; M Willingham; W Anderson; M Gallo
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

9.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

10.  A study of proteases and protease-inhibitor complexes in biological fluids.

Authors:  A Granelli-Piperno; E Reich
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  36 in total

1.  Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.

Authors:  I Bolon; M Devouassoux; C Robert; D Moro; C Brambilla; E Brambilla
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease.

Authors:  S L Wagner; J W Geddes; C W Cotman; A L Lau; D Gurwitz; P J Isackson; D D Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  A simple two-step purification of protease nexin.

Authors:  D H Farrell; W E Van Nostrand; D D Cunningham
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

4.  Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.

Authors:  B S Knudsen; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

5.  Binding of tissue plasminogen activator to human aortic endothelial cells.

Authors:  M A Sanzo; S C Howard; A J Wittwer; H M Cochrane
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

6.  Involvement of hormone processing in insulin-activated glucose transport by isolated cardiac myocytes.

Authors:  J Eckel; H Reinauer
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

Review 7.  Studies on rat mammary adenocarcinomas: a model for metastasis.

Authors:  I A Ramshaw; P Badenoch-Jones
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

8.  Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation.

Authors:  V L Turgeon; E D Lloyd; S Wang; B W Festoff; L J Houenou
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

9.  The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis.

Authors:  Sébastien Bergeron; Etienne Lemieux; Véronique Durand; Sébastien Cagnol; Julie C Carrier; Jacques G Lussier; Marie-Josée Boucher; Nathalie Rivard
Journal:  Mol Cancer       Date:  2010-10-13       Impact factor: 27.401

10.  Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages.

Authors:  U Lindahl; S O Kolset; J Bøgwald; B Osterud; R Seljelid
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.